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Evaluating the Migration Rates in Percutaneous Spinal Cord Stimulation Trials 
William Hirsch, Nikolaos Mouchtouris, MD, and Ashwini Sharan, MD 
Introduction: 
Spinal cord stimulation (SCS) provides symptom reduction in patients with chronic low 
back pain. The most common complication in SCS is percutaneous lead migration from initial 
placement site. It is our goal to determine whether using skin anchors during trial implantation 
reduces SCS trial lead migration rates compared to historical controls.  
Methods: 
 197 patients who underwent SCS trial placement at Thomas Jefferson University 
Hospital between 2015 and 2018 were considered for this study. Complete data including 
device impedance measurements and pre and post trial x-rays was collected on 12 historical 
control patients and 19 patients with leads secured using an anchor. 
Results: 
 The mean degree of lead migration was not statistically significantly different between 
the anchor group and control group in the right lead (0.71 mm (95% CI -6.24, 7.66, p=0.84) and 
the left lead (-0.85 mm (95% CI -7.70, 6.00, p=0.80). Additionally, there was no statistical 
difference in device impedance from the first day of the trial to the trial removal date between 
the anchor group and control group (-47.35 Ohms (95% CI -181.48, 86.78, p=0.47).  
Discussion: 
There was no significant reduction in lead migration or device impedance measurement 
in patients who underwent trial SCS with leads secured with an anchor compared to historical 
controls. This raises the question of whether the anchoring technique successfully reduces lead 
migration and emphasizes the importance of obtaining pre and post trial x-rays to evaluate lead 
migration. 
